Third Point Drops 8% In August

Sep 7 2007 | 1:17pm ET

After a rough August, hedge fund agitator Daniel Loeb might be inclined to write a venomous letter to himself.

His $3.7 billion Third Point Offshore Fund was down 8.3% in August, cutting its year-to-date returns to 6.8%.

According to the firm’s monthly investor letter, the fund’s “winners” last month include Lyondell Chemical, Alkermes Inc. and Ligand Pharmaceuticals, while “losers” included PDL BioPharma, Granite Construction and Leap Wireless. PDL BioPharma is the recipient of one of Loeb’s most recent trademark invective-filled missives.

The activist manager penned a letter to the company’s chairman, Patrick Gage, on Aug. 28 following PDL’s conference call demanding his resignation because Gage “gave the impression that repositioning the Company could be an alternative to selling the Company.” Loeb, who previously wanted the company to sell itself as a whole or in pieces, also cited the “lame duck” Gage’s emphasis on research and development strategies and “spotty” record at other public companies as catalysts for its demand for management change. New York-based Third Point currently owns a 9.7% stake in the company.

RELATED STORIES

Third Point's Loeb Seeks Second Head At Pharma
Loeb Seeks Head Of Pharmaceutical CEO


In Depth

Star Fund Managers Battered By Rocky Ride In Yields, Currencies

May 28 2015 | 6:05am ET

Some of the biggest names in the investment world have been whipsawed by the recent...

Lifestyle

Yale Receives $150 Million Gift from Blackstone’s Schwarzman

May 12 2015 | 12:10am ET

Yale University announced it has received a $150 million gift from Blackstone Group...

Guest Contributor

The Road To Tax Alpha

May 28 2015 | 5:36am ET

Tax-related alerts are increasingly helping investment managers harvest tax alpha...

 

Sponsored Content

Editor's Note